US 7811602
Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof
granted A61KA61K31/4745A61K33/32
Quick answer
US patent 7811602 (Liposomal formulations comprising dihydrosphingomyelin and methods of use thereof) held by Tekmira Pharmaceuticals Corporation expires Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Tekmira Pharmaceuticals Corporation
- Grant date
- Tue Oct 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K31/4745, A61K33/32, A61K9/1272, A61K9/1278